← All organizations

SRH Wald-Klinikum Gera GmbH

Academic/Hospital

Also known as: SRH Wald-Klinikum Gera GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Aug 31, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 3 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

gemcitabine

Phase 2 (1 own, 0 via acquisition)

vismodegib

Indications

Studied for

Recent trials (4)

NCT07092410OfficialPhase 4Aug 31, 2025
NCT07092410Lead sponsorPhase 4Aug 31, 2025
NCT03035188Lead sponsorPhase 2Jan 1, 2017
NCT01900327CollaboratorPhase 3Feb 1, 2014

Details

Last known activity: Aug 31, 2025